Home Biotech rivalry gets nasty in mudslinging battle over data
 

Keywords :   


Biotech rivalry gets nasty in mudslinging battle over data

2015-01-18 14:23:40| Biotech - Topix.net

The hot competition in biotechnology, where scientists race to cure complex diseases, boiled over last week as a company seeking to treat a deadly muscle disorder made an unusual move: It publicly criticized a rival's data. All BioMarin Pharmaceuticals Inc. of San Rafael, Calif., did was show investors two slides to illustrate an argument that its trial results were superior to those of Sarepta Therapeutics Inc. of Cambridge, Mass.

Tags: over data battle nasty

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
12.05Kline Analysts Detail the Medical Dispensing Skin Care Market
12.05Glo30 Starts 2024 Strong with 60% Growth
12.05Zevo On-Body Repellent Teams with American Hiking Society To Provide Bug Bite Defense
12.05L\'Oréals Brand Value Soars to $13.4 Billion
12.05Spate Unveils the Top Sustainability Trends Cycling Google Searches
12.05Oh K! is the Most Searched Beauty Brand in the World: Cosmetify
12.05Zahawi confirms nearly 5m paid for tax error
12.05Shein suppliers still work 75-hour weeks - report
More »